Zhang Lab

National University of Singapore

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	Beta-3 adrenergic receptor
Species	Homo sapiens (Human)
Gene	ADRB3
Synonym	ADRB Adrb-3 adrenergic receptor atypical beta-adrenoceptor beta 3-AR Beta-3 adrenoceptor Beta-3 adrenoreceptor beta3-adrenergic receptor beta3-adrenoceptor [ Show all ]
Disease	Urinary incontinence Diabetes Glaucoma Hypertension Irritable bowel syndrome Major depressive disorder; Obesity; Type 2 diabetes Major depressive disorder; Severe mood disorders Obesity Gastrointestinal disease Obesity; Type 2 diabetes Asthma; Chronic obstructive pulmonary disease Asthma Angina pectoris Overactive bladder disorder Type 2 diabetes [ Show all ]
Length	408
Amino acid sequence	MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS
UniProt	P13945
Protein Data Bank	N/A
GPCR-HGmod model	P13945
3D structure model	This predicted structure model is from GPCR-EXP P13945.
BioLiP	N/A
Therapeutic Target Database	T51408
ChEMBL	CHEMBL246
IUPHAR	30
DrugBank	BE0001012, BE0004872

Ligand

Name	clenbuterol
Molecular formula	C12H18Cl2N2O
IUPAC name	1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol
Molecular weight	277.189
Hydrogen bond acceptor	3
Hydrogen bond donor	3
XlogP	2.2
Synonyms	CHEBI:174690 Clenbuterolum DB01407 EINECS 256-529-4 KBio2_002044 Monores NCGC00163150-07 50306-03-1 Prestwick2_000345 ACM50499600 Spectrum5_001497 Benzenemethanol,4-amino-3,5-dichloro-a-[[(1,1-dimethylethyl)amino]methyl]-,(as)- BRD-A75726477-003-04-9 Contraspasmin (TN) DSSTox_CID_2833 FT-0665082 (+-)-clenbuterol KBio3_001829 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethan-1-ol NCGC00163150-01 4-Amino-3,5-dichloro-.alpha.-(((1,1-dimethylethyl)amino)methyl)benzenemethanol Planipart AB00053680-12 SCHEMBL4722 BC200547 STJMRWALKKWQGH-UHFFFAOYSA-N BSPBio_002609 Clenbuterol [BAN:INN] D0X5NX DTXSID7022833 IDI1_000794 (-)-4-amino-alpha-[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol KBioSS_002044 1-(4-amino-3,5-dichlorophenyl)-2-[(1,1-dimethylethyl)amino]ethanol NCGC00163150-04 4-Amino-alpha-[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol Prestwick0_000345 AC1L1EGH Spectrum4_000743 Benzenemethanol, 4-amino-3,5-dichloro-?-[[(1,1-dimethylethyl)amino]methyl]- Benzyl alcohol, 4-amino-alpha-((tert-butylamino)methyl)-3,5-dichloro- Clenbuterolum [INN-Latin] DivK1c_000794 FT-0665080 (+)-4-Amino-3,5-dichloro-alpha-[[(1,1-dimethylethyl)amino]methyl]benzenemethanol KBio2_004612 1-(4-amino-3,5-dichloro-phenyl)-2-(tert-butylamino)ethanol NAB 365 37148-27-9 NINDS_000794 50499-60-0 Prestwick3_000345 AKOS007930151 Spectrum_001564 BRN 1076467 Clenbuterol (INN) CTK1H4006 DSSTox_GSID_22833 FT-0701019 (+/-)-clenbuterol KBioGR_001066 1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol NCGC00163150-02 4-Amino-3,5-dichloro-alpha-(((1,1-dimethylethyl)amino)methyl)benzenemethanol Planipart [veterinary] AB00053680_13 SPBio_002330 BDBM27958 Tox21_112016 CAS-37148-27-9 Clenbuterol [INN:BAN] EINECS 253-366-0 KBio1_000794 (RS)-Clenbutero LS-30602 148C279 NCGC00163150-05 50306-01-9 Prestwick1_000345 ACM50306031 Spectrum4_001099 BENZENEMETHANOL, 4-AMINO-3,5-DICHLORO-alpha-(((1,1-DIMETHYLETHYL)AMINO)METHYL)- BPBio1_000451 CHEMBL49080 Contraspasmin dl-Clenbuterol FT-0665081 (+)-4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol KBio2_007180 1-(4-Amino-3,5-dichloro-phenyl)-2-tert-butylamino-ethanol NAB-365 4-Amino-.alpha.-[(tert-butylamino)methyl]-3,5-dichlorobenzyl alcohol P 5369 AB00053680 SBI-0051858.P002 API0002046 SR-01000721909-2 Tox21_112016_1 BSPBio_000409 clenbuterol (product) D07713 DSSTox_RID_76749 HMS2089I15 (-)-4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol KBioGR_001518 1-(4-Amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol # NCGC00163150-03 4-Amino-alpha-((tert-butylamino)methyl)-3,5-dichlorobenzyl alcohol Planipart [veterinary] (TN) AC-10284 Spectrum3_000975 Benzenemethanol, 4-amino-3,5-dichloro-.alpha.-[[(1,1-dimethylethyl)amino]methyl]- [ Show all ]
Inchi Key	STJMRWALKKWQGH-UHFFFAOYSA-N
Inchi ID	InChI=1S/C12H18Cl2N2O/c1-12(2,3)16-6-10(17)7-4-8(13)11(15)9(14)5-7/h4-5,10,16-17H,6,15H2,1-3H3
PubChem CID	2783
ChEMBL	CHEMBL49080
IUPHAR	N/A
BindingDB	27958
DrugBank	DB01407
Structure SDF download
Lipinski's druglikeness	This ligand satisfies Lipinski's rule of five.

Experimental Data

Parameter	Value	Reference	Database source
	N/A	N/A	DrugBank

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417